BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gomez D, De Rosa A, Addison A, Brooks A, Malik HZ, Cameron IC. Cetuximab therapy in the treatment of metastatic colorectal cancer: the future frontier? Int J Surg. 2013;11:507-513. [PMID: 23660586 DOI: 10.1016/j.ijsu.2013.04.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Benkhelifa S, Rafa H, Belhadef S, Ait-kaci H, Medjeber O, Belkhelfa M, Hetit S, Ait-younes S, De launoit Y, Moralès O, Mahfouf H, Delhem N, Touil-boukoffa C. Aberrant up-regulation of iNOS/NO system is correlated with an increased abundance of Foxp3+ cells and reduced effector/memory cell markers expression during colorectal cancer: immunomodulatory effects of cetuximab combined with chemotherapy. Inflammopharmacol 2019;27:685-700. [DOI: 10.1007/s10787-019-00566-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Dutheil F, Guillemin F, Biau J, Pham-Dang N, Saroul N, Clavère P, Lapeyre M. [Predictive factors for mandibular osteoradionecrosis after irradiation of head and neck cancers]. Cancer Radiother 2021;25:484-93. [PMID: 33836955 DOI: 10.1016/j.canrad.2021.03.002] [Reference Citation Analysis]
3 Di Carlo S, Yeung D, Mills J, Zaitoun A, Cameron I, Gomez D. Resection margin influences the outcome of patients with bilobar colorectal liver metastases. World J Hepatol 2016; 8(34): 1502-1510 [PMID: 28008341 DOI: 10.4254/wjh.v8.i34.1502] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
4 Jin KT, Chen B, Liu YY, Lan HU, Yan JP. Monoclonal antibodies and chimeric antigen receptor (CAR) T cells in the treatment of colorectal cancer. Cancer Cell Int 2021;21:83. [PMID: 33522929 DOI: 10.1186/s12935-021-01763-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Miroddi M, Sterrantino C, Simmonds M, Caridi L, Calapai G, Phillips RS, Stewart LA. Systematic review and meta-analysis of the risk of severe and life-threatening thromboembolism in cancer patients receiving anti-EGFR monoclonal antibodies (cetuximab or panitumumab). Int J Cancer 2016;139:2370-80. [PMID: 27450994 DOI: 10.1002/ijc.30280] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
6 Mohamed E, Adiamah A, Dunn WK, Higashi Y, Cameron IC, Gomez D. Outcome of indeterminate liver lesions on computed tomography in patients with colorectal cancer. Ann R Coll Surg Engl 2018;100:382-7. [PMID: 29692186 DOI: 10.1308/rcsann.2018.0070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang SZ, Zhou Y, Liu Q, Wang ZF, Wan B. A miR-30d antisense oligonucleotide inhibits proliferation and promotes apoptosis of colon cancer cells. Shijie Huaren Xiaohua Zazhi 2013; 21(22): 2143-2150 [DOI: 10.11569/wcjd.v21.i22.2143] [Reference Citation Analysis]
8 Renaud S, Alifano M, Falcoz PE, Magdeleinat P, Santelmo N, Pagès O, Massard G, Régnard JF. Does nodal status influence survival? Results of a 19-year systematic lymphadenectomy experience during lung metastasectomy of colorectal cancer. Interact Cardiovasc Thorac Surg 2014;18:482-7. [PMID: 24442624 DOI: 10.1093/icvts/ivt554] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]